Life Biosciences

Longevity-focused biotech innovator

Growth
Cambridge, MA, USA
Founded 2017
Website

About

Life Biosciences, founded in 2017, focuses on developing therapeutics that target human aging processes to extend healthy lifespan. The company operates a portfolio approach, advancing multiple programs addressing core aging pathways. Their business model includes in-house drug discovery and development, aiming to bring longevity therapies to market. Life Biosciences is in growth stage with robust funding to support pivotal clinical trials and regulatory progress toward transformative age-related disease treatments.

Products

  • Longevity Therapeutics Pipeline — Collection of drug candidates targeting multiple aging pathways to improve healthspan.
    Customer sectors: biotech/pharma R&D, healthcare

Company Details

Sector Deep Tech
Category Biotech & Therapeutics
Stage Growth
Total Funding $80.0M
Employees 51-200
Last Funded April 8, 2026
Last Round $80.0M

Market research & competitive positioning

Source-backed TAM / SAM / SOM sizing, displacement analysis, and an interactive peer positioning map for Life Biosciences — available to members.

Create a free account Sign in